New selective estrogen receptor modulators (SERMs) in development - Test2 - elhamkhani - TriplyDB

New selective estrogen receptor modulators (SERMs) in development

New selective estrogen receptor modulators (SERMs) in development

http://www.wikidata.org/entity/Q33988035

about

Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.The management of sacral stress fractures: current concepts Osteoporosis and gastrointestinal disease.Research resource: Transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes Progress in endocrine approaches to the treatment and prevention of breast cancer Antiresorptive therapies for osteoporosis: a clinical overview.Models and screening assays for drug discovery in osteoporosis.Computational methods for the design of potent aromatase inhibitors.Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.EADB: an estrogenic activity database for assessing potential endocrine activity.

P2860

Q28703563-1E146AEE-6654-44E0-83E8-8341473503E9 Q30454254-95D1861A-68D0-4BE4-B38C-530B56BFB493 Q30470297-5F660DCA-20A6-41F3-BA9B-20899586DF19 Q34178759-239DA128-66C5-45B0-8376-676C383F7854 Q36065502-2DE8D7CB-A7BA-418C-ABDA-E608735F6E81 Q36457511-76945425-1ABF-4870-A5FC-8C1297C9A2A1 Q37926914-2FAA99DC-3049-477C-A8F6-322DC08E914F Q38028513-7A42A63F-5848-4F6F-A250-64987885B1AE Q38078417-9F6F27AA-E5C4-44F1-9A59-A2305BD2B90D Q39735325-765CDE4D-77F3-4036-92EC-6D399D1B2D05 Q46021619-C285B43F-6B81-46C8-A3ED-2D3E59712C5E

P2860

New selective estrogen receptor modulators (SERMs) in development

http://www.wikidata.org/entity/Q33988035

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

New selective estrogen receptor modulators (SERMs) in development

@ast

New selective estrogen receptor modulators (SERMs) in development

@en

type

label

New selective estrogen receptor modulators (SERMs) in development

@ast

New selective estrogen receptor modulators (SERMs) in development

@en

prefLabel

New selective estrogen receptor modulators (SERMs) in development

@ast

New selective estrogen receptor modulators (SERMs) in development

@en

P1433

Q33988035-9B9CC65D-453F-4241-94CD-E876031E675E

P1476

Q33988035-77DA1A66-FEFF-4492-B130-E97EB08C1251

P2093

Q33988035-9E65F718-E242-4413-9CA5-532172129207

P2860

Q33988035-04DF6C8A-F83D-4E88-A700-917BBA785848

Q33988035-060DD023-BFBC-4FA7-8DA7-2F1A4C5B207A

Q33988035-3C7B1090-A72B-40F0-A111-5621AA805EC8

Q33988035-6F7357D2-EA40-496B-9F41-E4447CC80AC3

Q33988035-9041142D-1B49-4444-B076-F43F6A62D002

Q33988035-9EC1393F-FBF4-4341-A233-38068CE87FAA

Q33988035-DF822ED5-B869-4CF9-B1AC-59A304F953F8

Q33988035-EC35EB17-7CDC-4C50-A491-19D91247FC72

P2888

Q33988035-87E91A42-789C-4C5D-8986-40A7E3FB3464

P304

Q33988035-E93F74C5-B054-4B4B-BD42-BBCF26A21650

P31

Q33988035-2935DB7A-0A66-40A8-806C-B1026C1517B8

Q33988035-C4AEE911-6F68-4917-88F7-B6CE78D5F6C0

P356

Q33988035-478A6539-7854-4937-85E6-4654D9AA66D5

P433

Q33988035-4DC902BE-1EF8-48A4-BB54-9A1605869371

P478

Q33988035-49B4D2FA-851A-4399-A47D-25711EF9CDAF

P577

Q33988035-2638278D-564E-49A4-964E-A4F15CCA66CF

P5875

Q33988035-38D3A94A-C4BB-4368-8942-F8F7957D3F13

P6179

Q33988035-708D9E78-80DB-4FF2-BC43-6DBBA624133D

P698

Q33988035-AD2129E8-8C9D-497E-9368-FE08294CDF3C

P921

Q33988035-2E5A870C-CBA6-49BD-81B5-D1C5C4B34DFE

Q33988035-F889047A-CDDE-41A6-A390-0C03A1D095A5

P932

Q33988035-8A4F00DB-E83D-4A15-A4D3-ADF1EE45F6EC

P356

S11914-010-0025-0

P1433

Current osteoporosis reports

P1476

New selective estrogen receptor modulators (SERMs) in development

@en

P2093

Stuart L Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

Lasofoxifene in postmenopausal women with osteoporosis

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.

Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.

P2888

s11914-010-0025-0

P304

151-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-010-0025-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45094745

http://www.w3.org/2001/XMLSchema#string

P6179

1033855777

http://www.w3.org/2001/XMLSchema#string

P698

20603714

http://www.w3.org/2001/XMLSchema#string

P921

hormone antagonist

P932

2902741

http://www.w3.org/2001/XMLSchema#string